Santagata Davide: Can Targeting Inflammation Help Prevent Thrombosis?
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Internal and Emergency Medicine, adding:
“Can targeting inflammation help prevent thrombosis?
Happy to share our new review in Internal and Emergency Medicine:
‘Inflammation and thrombosis: from pathophysiology to future treatments’.
We explore how inflammation drives thrombosis—and how these mechanisms could inform future therapies.
Anti-inflammatory treatments have shown benefits in selected cardiovascular settings. Can we translate this progress into venous thromboembolism prevention?
This remains an open question.
Many thanks to all my co-authors for this collaboration!”
Title: Inflammation and thrombosis: from pathophysiology to future treatments
Authors: Davide Santagata, Laura Giovenali, Emanuele Guerrieri, Lorenzo Falsetti, Alessandro Squizzato, Gianluca Moroncini
Find more posts featuring Santagata Davide on Hemostasis Today.
-
Oct 30, 2026, 17:38Patrick Ellsworth: Supporting Patients and Families Through Bleeding Disorders Awareness and Community Initiatives
-
Oct 30, 2026, 17:33Ed Shovelin: Comparative Hemostatic Performance of CRP-A and Equine Fibrillar Collagen
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management
-
Oct 30, 2026, 16:01Marilena Vrana: The Case for Retaining Immunoglobulins on the EU Critical Medicines List